Vaccines (Mar 2024)

SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges

  • Diary Juliannie Ny Mioramalala,
  • Rila Ratovoson,
  • Paul Alain Tagnouokam-Ngoupo,
  • Hermine Abessolo Abessolo,
  • Joseph Marie Mindimi Nkodo,
  • Georges Bouting Mayaka,
  • Pierre Claude Tsoungui Atangana,
  • Fanirisoa Randrianarisaona,
  • Pulchérie Pélembi,
  • Romaric Nzoumbou-Boko,
  • Cathy Sandra Goimelle Coti-Reckoundji,
  • Alexandre Manirakiza,
  • Anjanirina Rahantamalala,
  • Rindra Vatosoa Randremanana,
  • Mathurin Cyrille Tejiokem,
  • Matthieu Schoenhals

DOI
https://doi.org/10.3390/vaccines12040363
Journal volume & issue
Vol. 12, no. 4
p. 363

Abstract

Read online

Background: The COVID-19 pandemic has affected Madagascar, Cameroon, and the Central African Republic (CAR), with each experiencing multiple waves by mid-2022. This study aimed to evaluate immunity against SARS-CoV-2 strains Wuhan (W) and BA.2 (BA.2) among healthcare workers (HCWs) in these countries, focusing on vaccination and natural infection effects. Methods: HCWs’ serum samples were analyzed for neutralizing antibodies (nAbs) against W and BA.2 variants, with statistical analyses comparing responses between countries and vaccination statuses. Results: Madagascar showed significantly higher nAb titers against both strains compared to CAR and Cameroon. Vaccination notably increased nAb levels against W by 2.6-fold in CAR and 1.8-fold in Madagascar, and against BA.2 by 1.6-fold in Madagascar and 1.5-fold in CAR. However, in Cameroon, there was no significant difference in nAb levels between vaccinated and unvaccinated groups. Conclusion: This study highlights the complex relationship between natural and vaccine-induced immunity, emphasizing the importance of assessing immunity in regions with varied epidemic experiences and low vaccination rates.

Keywords